OrthoPediatrics exec gets stock grant, sells for tax

OrthoPediatrics Corp President of Scoliosis Gregory A. Odle reported a stock compensation event combined with a tax-related share sale.

Accepted by SEC EDGAR 03/17/2026 - 04:18 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

OrthoPediatrics Corp President of Scoliosis Gregory A. Odle reported a stock compensation event combined with a tax-related share sale. He received a grant of 47,380 shares of common stock as a restricted stock award. The next day, 8,433 shares were sold specifically to satisfy tax withholding obligations upon vesting of restricted shares, according to the footnote. After these transactions, he directly holds 187,735 shares of common stock, which the disclosure states includes restricted stock awards totaling 121,054 shares.

Insider Trade Summary

Net Seller: 8,433 shares

Net Sell 2 txns

Insider Odle Gregory A

Role President of Scoliosis

Sold 8,433 shs ($145K)

Share of Position Sold 4.3%

Type	Security	Shares	Price	Value
Sale	Common Stock	8,433	$17.25	$145K
Grant/Award	Common Stock	47,380	$0.00	$0.00

Holdings After Transaction: Common Stock — 187,735 shares (Direct)

Holdings Before and After: Common Stock, 148,788 to 187,735 shares (Direct)

Other Insiders: 4 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.
2. F2. Includes restricted stock awards totaling 121,054 shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did OrthoPediatrics (KIDS) executive Gregory A. Odle report?

Gregory A. Odle reported a stock grant and a related share sale. He received 47,380 shares of OrthoPediatrics common stock as a restricted stock award and sold 8,433 shares to cover tax withholding obligations tied to the vesting of restricted shares.

How many OrthoPediatrics (KIDS) shares did Gregory A. Odle sell, and for what purpose?

Gregory A. Odle sold 8,433 shares of OrthoPediatrics common stock. A footnote explains the shares were sold solely to satisfy tax withholding obligations arising from the vesting of restricted shares, indicating this was a tax-related transaction rather than a discretionary portfolio decision.

What stock award did OrthoPediatrics (KIDS) grant to executive Gregory A. Odle?

Gregory A. Odle was granted 47,380 shares of common stock. The Form 4 describes this as a grant, award, or other acquisition of OrthoPediatrics shares, representing compensation in the form of restricted stock rather than an open-market purchase.

How many OrthoPediatrics (KIDS) shares does Gregory A. Odle hold after these transactions?

After the reported transactions, Gregory A. Odle holds 187,735 shares. The filing states this direct holding includes restricted stock awards totaling 121,054 shares, giving a combined picture of his owned and restricted OrthoPediatrics common stock position.

Are Gregory A. Odle’s OrthoPediatrics (KIDS) transactions mainly compensation-related?

Yes, the reported transactions are primarily compensation-related. The Form 4 shows a large restricted stock award of 47,380 shares and a smaller 8,433-share sale explicitly described as covering tax withholding obligations from restricted share vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Odle Gregory A

(Last) (First) (Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW IN 46582

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President of Scoliosis

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		A		47,380	A	$0	196,168	D
Common Stock	03/16/2026		S		8,433(1)	D	$17.25	187,735(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.

2. Includes restricted stock awards totaling 121,054 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.